Schmerzmedizin 4 / 2019

Literatur 1. Van den Meent H et al. Safety of „pain exposure“ physical therapy in patients with complex regional pain syndrome type 1. Pain 2011;152:1431-8 2. Sandroni P et al. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 2003;103:199-207 3. De Mos M et al. The incidence of complex regional pain syndrome: a populationbased study. Pain 2007;129:12-20 4. Stanton-Hicks M. Plasticity of complex regional pain syndrome (CRPS) in children. Pain Med 2010;11:1216-23 5. Schlereth T et al. Inflammation in CRPS: role of the sympathetic supply. Auton Neurosci 2014;182:102-7 6. Gustin SM et al. NMDA-receptor antagonist and morphine decrease CRPS-pain and cerebral pain representation. Pain 2010;151:69-76 7. Barad MJ et al. Complex regional pain syndrome is associated with structural abnormalities in pain-related regions of the human brain. J Pain. 2014;15:197-203 8. Seifert F et al. Differential endogenous pain modulation in complex- regional pain syndrome. Brain 2009;132:788-800 9. komplexer-regionaler-schmerzsyndromecrps-2018 10. Erpelding N et al. Rapid treatment-induced brain changes in pediatric CRPS. Brain Struc Funct 2016;221:1095-111 11. McCabe CS et al. Mirror visual feedback for treatment of CRPS (type 1). Curr Pain Headache Rep 2008;12:103-7 12. Sigtermans MJ et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain 2009;145:304-11 13. Kern U et al. Topisches Ambroxol zur Therapie des CRPS – eine neue Option. Poster Deutscher Schmerzkongress Mannheim, 2016 14. Chopra P, Cooper M. Treatment of complex regional pain syndrom (CRPS) using low dose Naltrexon (LDN). J Neuroimmune Pharmacol 2013;8:470-6 15. Stanton TR et al. Local anaesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev 2013;(8): CD004598 Zer tif izier te For tbildung Komplexes regionales Schmerzsyndrom 32 Schmerzmedizin 2019; 35 (4)